ContributorsPublishersAdvertisers

#Pfizer Biontech

christopherreeve.org

​What Do You Need to Know About Novavax?

To help you navigate the progress and availability of COVID-19, we'll discuss some questions you may have about Novavax's Adjuvanted. Why is Novavax Authorized but not Approved by the FDA?. Novavax had a contract with the federal government when Operation Warp Speed began. However, manufacturing issues slowed down a quick...
Picture for ​What Do You Need to Know About Novavax?
News-Medical.net

Researchers compare the risk of myocarditis between Pfizer and Moderna COVID-19 vaccines

Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases of heart inflammation with either vaccine are very rare, according to a study in the Journal of the American College of Cardiology. The study showed males younger than 40 years old who received the Moderna vaccine were shown to have the highest rates of myocarditis, which according to the authors, may have implications for choosing specific vaccines for certain populations.
Picture for Researchers compare the risk of myocarditis between Pfizer and Moderna COVID-19 vaccines
MedicalXpress

Which COVID vaccine you get could affect your myocarditis risk

Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases of heart inflammation with either vaccine are very rare, according to a study in the Journal of the American College of Cardiology. The study showed males younger than 40 years old who received the Moderna vaccine were shown to have the highest rates of myocarditis, which according to the authors, may have implications for choosing specific vaccines for certain populations.
Picture for Which COVID vaccine you get could affect your myocarditis risk
ScienceBlog.com

Which COVID vaccine you get can impact myocarditis risk

Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases of heart inflammation with either vaccine are very rare, according to a study in the Journal of the American College of Cardiology.
Revyuh - Latest Breaking News

New Study Shows Higher Rates Of Heart Inflammation With Moderna Vs. Pfizer

After a second dose of the Moderna Spikevax COVID-19 vaccine, the risk of myocarditis, pericarditis, or myopericarditis is two to three times higher than with the Pfizer BioNTech COVID-19 vaccine. However, cases of heart inflammation are very rare with either vaccine, according to a study in the Journal of the...
honestcolumnist.com

Which COVID vaccine you get can impact myocarditis risk: Study shows higher rates of heart inflammation with Moderna vs. Pfizer, but overall risk still very low

Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases of heart inflammation with either vaccine are very rare, according to a study in the Journal of the American College of Cardiology. The study showed males younger than 40 years old who received the Moderna vaccine were shown to have the highest rates of myocarditis, which according to the authors, may have implications for choosing specific vaccines for certain populations.
vervetimes.com

Study shows higher rates of heart inflammation with Moderna vs. Pfizer, but overall risk still very low — ScienceDaily

Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases of heart inflammation with either vaccine are very rare, according to a study in the Journal of the American College of Cardiology. The study showed males younger than 40 years old who received the Moderna vaccine were shown to have the highest rates of myocarditis, which according to the authors, may have implications for choosing specific vaccines for certain populations.
Science Daily

Which COVID vaccine you get can impact myocarditis risk

Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases of heart inflammation with either vaccine are very rare, according to a study in the Journal of the American College of Cardiology. The study showed males younger than 40 years old who received the Moderna vaccine were shown to have the highest rates of myocarditis, which according to the authors, may have implications for choosing specific vaccines for certain populations.
Science 2.0

Moderna Spikevax COVID-19 Vaccine Linked To Higher Myocarditis Risk Than Pfizer BioNTech

Heart inflammation after a COVID-19 vaccine is very rare but epidemiology exists to vreate exploratory between products and outcomes and a recent analysis showed incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine compared to the Pfizer BioNTech COVID-19 vaccine.